Spero Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $64.4M | $110.5M | $52.9M |
| FY2025 | $9.9M | $68.9M | $40.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $64.4M | $110.5M | $52.9M |
| FY2025 | $9.9M | $68.9M | $40.3M |